A Rebuttal to Mark Lynas’ GMO Reversal
By Jason Mark,
Earth Island Journal
| 01. 11. 2013
If you want to get your name splattered all over the web, there’s nothing like recanting your once strongly held beliefs. Give a big
mea culpa speech telling the world how wrong you have been, and you’ll get far more attention for your auto-rebuttal than you ever received for your original ideas. When it comes to ideological U-turns the media are like moths to a flame. (Never mind that, as Whitman said, “consistency is the hobgoblin of small minds.”)
In this case, I’m talking about the recent “big news” that one-time GMO critic
Mark Lynas — a Brit who at least once took direct action to rip GM trial crops out of the ground — has come out as a supporter of the technology he once abhorred. You can find write-ups about it from
Andrew Revkin and
Slate and the
LA Times and
The New Yorker’s Michael Specter. I even got an email from the folks at the No on 37 campaign (the people who successfully fought a GMO labeling referendum in California) trumpeting the news.
Here’s the opening...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...